这是不是杂志的经营之道？老外的杂志都开始用实力自夸了。

邮件如下：

Announcing our new impact factor

The Lancet Infectious Diseases editorial team is pleased to announce our impact factor has increased to 17.39, retaining the #1 ranking among 70 journals in the infectious diseases category (2011 Journal Citation Reports®, ©Thomson Reuters 2012).

Please see below a list of the top 10 highly-cited articles which significantly contributed to our new impact factor.

We would like to thank our readers, authors, reviewers and editorial board for their support in making the journal the authoritative and independent voice in the global field of infectious diseases.

Sincerely yours,

John McConnell
Editor
The Lancet Infectious Diseases

Our commitment to quality

We are committed to publishing the highest quality research, review and opinion. We deliver on our commitment by:

We are pleased to present the 10 most highly-cited and ground-breaking articles which significantly contributed to our new impact factor.

Top 10 most cited articles
(Source: Scopus, June 2012; 2010-2011)

Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
(2010 Article) The Lancet Infectious Diseases, 10 (9)
Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, et.al.
Read on TheLancet.com

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
(2010 Review) The Lancet Infectious Diseases, 10 (4)
Müller M, Wandel S, Colebunders R, Attia S, Furrer H, Egger M
Read on TheLancet.com

Changes in the burden of malaria in sub-Saharan Africa
(2010 Review) The Lancet Infectious Diseases, 10 (8)
O'Meara WP, Mangeni JN, Steketee R, Greenwood, B
Read on TheLancet.com

Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study
(2011 Article) The Lancet Infectious Diseases, 11 (9)
Bielaszewska M, Mellmann A, Zhang W, Köck R, Fruth A, et.al.
Read on TheLancet.com

Dissemination of NDM-1 positive bacteria in the New Delhi environment and its implications for human health: an environmental point prevalence study
(2011 Article) The Lancet Infectious Diseases, 11 (5)
Walsh TR, Weeks J, Livermore DM, Toleman MA
Read on TheLancet.com
Possible underlying mechanisms for successful emergence of the Mycobacterium tuberculosis Beijing genotype strains
(2010 Review) The Lancet Infectious Diseases, 10 (2)
Parwati I, van Crevel R, van Soolingen D
Read on TheLancet.com

Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
(2010 Article) The Lancet Infectious Diseases, 10 (8)
Kumar D, Michaels MG, Morris MI, Green M, Avery RK, et. al.
Read on TheLancet.com

Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
(2010 Review) The Lancet Infectious Diseases, 10 (9)
Caminero JA, Sotgiu G, Zumla A, Migliori GB
Read on TheLancet.com
Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Europe
(2010 Review) The Lancet Infectious Diseases, 10 (4)
Otter JA, French GL
Read on TheLancet.com

Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum β-lactamase producing, Enterobacteriaceae infections: a systematic review
(2010 Review) The Lancet Infectious Diseases, 10 (1)
Falagas ME, Kastoris AC, Kapaskelis AM, Karageorgopoulos DE
Read on TheLancet.com